Destaques sobre o mercado de saúde

Five Predictions for Biotech and Medicine in 2012 by @matthewherper on @forbes

1. We’ll see more super-expensive drugs. Charging $100,000, $200,000, or even $500,000 per patient per year is the most successful strategy in the drug business. One case study: In 2008, the Joint Economic Committee of the Senate and House heard testimony alleging that drugs for rare, orphan diseases were getting too expensive. One parent testified that the treatment […]